Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study).

Blood (2009) 114 (22): 1638.

https://doi.org/10.1182/blood.V114.22.1638.1638

Published: 2009

Journal Articles

High-Sensitivity C-Reactive Protein (hs-CRP) and Pentraxin 3 (PTX3) Are Increased in Essential Thrombocythemia and Polycythemia Vera.

Tiziano Barbui, Alessandra Carobbio, Barbara Bottazzi, Pio Zilio, Anna Salvi, Ivan Cuccovillo, Silvia Salmoiraghi, Guido Finazzi, Alberto Mantovani, MD, Alessandro Rambaldi, MD

Blood (2009) 114 (22): 1911.

https://doi.org/10.1182/blood.V114.22.1911.1911

Published: 2009

Journal Articles

Selective Targeting of the JAK2 V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.

Vittoria Guerini, PhD, Valentina Barbui, PhD, Orietta Spinelli, PhD, Anna Salvi, Chiara Dellacasa, MD, Martino Introna, MD, Tiziano Barbui, MD, Josée Golay, PhD, Alessandro Rambaldi, MD

Blood (2007) 110 (11): 555.

https://doi.org/10.1182/blood.V110.11.555.555

Published: 2007

Journal Articles

Potent Inhibition of EEC Colony Formation in JAK2 V617F PV and ET by Low Doses of ITF2357, a New Histone Deacetylase Inhibitor.

Vittoria Guerini, PhD, Orietta Spinelli, Biol Sc, Anna Salvi, Guido Finazzi, MD, Tiziano Barbui, MD, Martino Introna, MD, Josee Golay, Biol Sc, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 2702.

https://doi.org/10.1182/blood.V108.11.2702.2702

Published: 2006

Journal Articles

Risk-Adapted Therapy of Adult Acute Myeloid Leukemia (AML): Safety and Efficacy of Repetitive HD-ARA-C Courses with Low-Dose Autologous Blood Stem Cell Support.

Tamara Intermesoli, MD, Elena Oldani, Biol.Sci., Caterina Micò, MD, Vittoria Guerini, Biol.Sci., Anna Salvi, Emanuela Ruggeri, Andrea Rossi, MD, Ursula Giussani, Biol.Sci., Piero Bellavita, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Renato Bassan, MD

Blood (2005) 106 (11): 2934.

https://doi.org/10.1182/blood.V106.11.2934.2934

Published: 2005

Journal Articles

Potent Cytotoxicity Against Multiple Myeloma and Acute Myeloid Leukemia Cells by a New Histone Deacetylase Inhibitor ITF2357.

Alessandro Rambaldi, MD, Caterina Micò, Lucia Cuppini, Marcello Domenghini, Gian Maria Borleri, Anna Maria Barbui, MD, Flavio Leoni, Paolo Mascagni, MD, Anna Salvi, Josee Golay, PhD, Martino Introna, MD

Blood (2005) 106 (11): 3361.

https://doi.org/10.1182/blood.V106.11.3361.3361

Published: 2005

Journal Articles

Acute Lymphoblastic Leukaemia Cells Carrying the t(12;21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis.

Josee Golay, PhD, Chiara Cortiana, Giovanni Cazzaniga, Anna Salvi, Massimiliano Manganini, Orietta Spinelli, Renato Bassan, MD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD, Martino Introna, MD

Blood (2005) 106 (11): 872.

https://doi.org/10.1182/blood.V106.11.872.872

Published: 2005

Journal Articles

Time- and Dose-Response Relationships of Imatinib Mesylate (Glivec) Therapy for Chronic Hypereosinophilic Syndromes.

Renato Bassan, MD, Sara Acerboni, BSc, Silvia Mappa, MD, Piera Viero, MD, Federica Delaini, BSc, Giuseppe Rossi, Valentina Rossi, A. Vannucchi, MD, Eros Di Bona, MD, Emanuela Ruggeri, Anna Salvi, Ursula Giussani, BSc, Francesca Rancati, MD, Tamara Intermesoli, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD

Blood (2005) 106 (11): 2596.

https://doi.org/10.1182/blood.V106.11.2596.2596

Published: 2005

NARROW

Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study).

High-Sensitivity C-Reactive Protein (hs-CRP) and Pentraxin 3 (PTX3) Are Increased in Essential Thrombocythemia and Polycythemia Vera.

Selective Targeting of the JAK2 V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.

Potent Inhibition of EEC Colony Formation in JAK2 V617F PV and ET by Low Doses of ITF2357, a New Histone Deacetylase Inhibitor.

Risk-Adapted Therapy of Adult Acute Myeloid Leukemia (AML): Safety and Efficacy of Repetitive HD-ARA-C Courses with Low-Dose Autologous Blood Stem Cell Support.

Potent Cytotoxicity Against Multiple Myeloma and Acute Myeloid Leukemia Cells by a New Histone Deacetylase Inhibitor ITF2357.

Acute Lymphoblastic Leukaemia Cells Carrying the t(12;21) Translocation Are Highly Sensitive to Alemtuzumab Mediated Cell Lysis.

Time- and Dose-Response Relationships of Imatinib Mesylate (Glivec) Therapy for Chronic Hypereosinophilic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only